Do you have an innovative idea? Are you looking for funding, collaboration, and mentorship?

FFMI fastPACE is a four-week biomedical and commercialization course designed for life science innovators with an early-stage project. The course helps participants prepare a successful business case for funding and development partnerships. FFMI fastPACE is open to biomedical innovators across the University of Michigan, and across the state, region, and nation.

Registration is now available for the Spring 2022 cohort, to be held virtually, beginning Friday, April 29. Sign up today! Registration closes on Friday, April 15 at 11:59pm.

Questions? Email Jon Servoss, FFMI Director of Commercialization Education.

The Coulter Program collaboratively works with U-M faculty to develop medical device concepts invented at U-M and license the related IP rights to medical device companies who complete development and seek FDA approvals. The Coulter Program has two award programs – Enlighten and Evolve.

Enlighten Award - Awardees receive direct mentoring from medical device industry experts and outside investors, market, regulatory, and IP landscape assessments, and introductions to medical device companies. Program deliverables culminate with product strategic plans. Enlighten awardees will be invited to pitch for Evolve Awards to execute on strategic plans.

Questions? Contact Thomas Marten, Managing Director, Coulter Program, at tmarten@umich.edu or 734-647-1680.

The University of Michigan Space Institute seeks to spur campus-wide, cross-disciplinary collaborations to address some of the most challenging problems in the field of space medicine.

In addition to helping humans thrive in space, discoveries will have great potential to improve health on Earth, informing areas such as remote care, advanced surgical techniques, and the aging process, among many others. The emergence of a new era of space exploration, combined with funding opportunities from federal agencies and the private sector, provides a unique opportunity for us to develop shared research questions and agendas that will broadly benefit human health.

The Michigan Institute for Clinical & Health Research (MICHR) and the Space Institute will be hosting a Research Jam in the first quarter of 2022 to collectively vision the future of space medicine at U-M and to begin building a diverse community of interested colleagues.

Please complete this brief survey if you are interested in participating in this initial conversation.

Research Development, part of Grant Services and Analysis in the Medical School Office of Research, is hosting Dr. Thomas Greenwell for an upcoming lunch and learn webinar. Dr. Greenwell is a Program Director at the National Eye Institute (NEI) at NIH, and he’ll talk about the role of an NIH Program Officer (PO) and provide “tips & tricks” for contacting and interacting with POs at NIH. He will also answer questions from event participants.

Interested in learning more about a career opportunity in strategic research administration for Ph.D.s and postdocs at U-M? The UMMS Research Administration Fellowship is a two-year paid, full-time position, starting this September, where fellows learn to connect science and business competencies to engage in innovative projects that enhance biomedical research. Applications are open.

RSVP here to get the link to the upcoming virtual Ask-A-Fellow session with current fellows, on Wednesday, February 9 from 1:00pm-2:00pm.

Join the Clinical Trials Support Office for the latest installment of Working with Industry on Thursday, February 10 from 5:00pm-6:30pm.

During the event, we will speak with the research teams behind two Michigan Medicine virtual trials, MiPACT and CHIEF-HF, as well as get an industry perspective from our partners at IQVIA and Genentech.

In this ever-changing technological landscape, virtual clinical trials offer new opportunities for research teams, and, since the start of the pandemic, they have proved to be an advantage when many traditional in-person trials were put on pause.

Teams interested in switching to the virtual space may be particularly interested as we hope to discuss the types of research questions that are amenable to virtual implementation, and outline key logistical considerations and requirements related to team infrastructure, informed consent, data collection, and regulatory requirements.

The Rare Disease Day Educational Conference will take place virtually Friday, February 25 - Saturday, February 26 from 10:15am-5:00pm.

If you have exciting research presentations, case reports, or clinical trial results to share with the Rare Disease Community, please submit a 250-word abstract by Saturday, February 12. Six to eight abstracts will be selected for a two-minute presentation by Wednesday, February 16. 

 

Abstracts (written in Microsoft Word with Arial 12 pt. font) can be emailed to Carman Richison at crichson@umich.edu.

 

Abstracts submitted for other professional society meetings can be presented as “encore” work. Please add a comment that the work is an “encore” submission, and include the original meeting where the work was presented as a footnote to the abstract.

Work not selected for presentation will be distributed to registrants. The distributed material can contain the abstract, a PowerPoint single-slide summary of the work, or an optional pre-recorded two to five-minute Zoom presentation video (can be downloaded as an MPEG file from Zoom and sent) for viewing. 

Asahi Kasei Pharma is calling for new proposals related to drug discovery research as part of its efforts for open innovation and to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes, and enterprises around the world.

Proposals are solicited concerning new drug seeds (drug target and drug candidate) and technologies in the therapeutic fields of autoimmune disease, critical care medicine, neurodegenerative disease, pain and neuropathy, bone disease, and drug discovery platform technology.

Please contact Debra Grega, FFMI Business Development Director, for further details.

The 2022 Massey TBI Grand Challenge kicks off on March 3, and it's going to be bigger and better than ever. The Max Harry Weil Institute for Critical Care Research, formerly the Michigan Center for Integrative Research in Critical Care, is thrilled to announce that, this year, there will be a grand total of $1 MILLION available to fund multidisciplinary teams proposing high-risk ideas and innovations addressing the golden hours of traumatic brain injury.

Join Precision Health for a half-day, in-person/remote hybrid event with the theme "Advancing Responsible Healthcare Innovation Using Artificial Intelligence."

This event will focus on the transformative impact artificial intelligence and machine learning are having on precision healthcare. Attendees will hear from thought leaders, researchers, and practitioners who will guide the conversation from big picture concepts (what is the vision of AI in healthcare and how do we realize it?), to the importance of applying new research tools responsibly and inclusively, to the need for integrating new methods and inclusivity considerations into training for clinicians, researchers, and other learners.

To better navigate the complexities of the U-M biomedical research enterprise, visit the Research Project Lifecycle. This interactive tool provides an overview of the resources available to you, not only within the Medical School Office of Research but also across the University of Michigan.